Reports

Sale

Extracorporeal Membrane Oxygenation Market

Global Extracorporeal Membrane Oxygenation Market Size, Analysis: By Component: Pumps, Oxygenator, Controllers, Cannula, Accessories; By Modality: Veno-Arterial, Veno-Venous, Arterio-Venous; By Patient Type: Neonates, Pediatric, Adult; By Application: Respiratory, Cardiac, Others; Regional Analysis; Supplier Landscape; 2024-2032

Global Extracorporeal Membrane Oxygenation Market Outlook

The global Extracorporeal Membrane Oxygenation market attained a value of USD 241.67 million in 2023, driven by the increasing prevalence of respiratory and cardiac diseases across the globe. The market size is anticipated to grow at a CAGR of 4.8% during the forecast period of 2024-2032 to achieve a value of USD 368.53 million by 2032.

 

Global Extracorporeal Membrane Oxygenation Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Pumps Segment to Account for a Significant Market Share of the Global Extracorporeal Membrane Oxygenation Industry

Based on component, the pumps segment is predicted to hold a significant market share in the extracorporeal membrane oxygenation industry. The pumps are an essential element in the ECMO machine that helps pump the blood from the patient's body to the machine and then back. The increased implementation of ECMO machines with the increasing patient population globally is driving the demand for pumps. Moreover, in terms of application, the respiratory segment is estimated to observe a significant growth as a result of the increasing respiratory diseases, especially among the geriatric population, and the rising levels of air pollution in the world. These factors are expected to contribute to the overall market growth in the forecast period.

 

North America to Occupy a Substantial Market Share in the Global Extracorporeal Membrane Oxygenation Industry

North America is estimated to hold a substantial share of the extracorporeal membrane oxygenation industry in the forecast period. This growth can be attributed to the presence of leading manufacturers of ECMO machines in the region. In addition, the growing geriatric population, susceptible to most cardiopulmonary diseases, is leading to increased investments in ECMO technology by the government and the manufacturers in the region. Furthermore, according to the World Population Report issued by the UN in 2019, the population ageing phenomenon is increasingly being observed worldwide. In North America, particularly, the ratio is expected to rise from 30 persons aged above 65 per 100 people in 2019 to 49 people aged above 65 per 100 people in 2050.

 

Extracorporeal Membrane Oxygenation: Market Segmentation

Extracorporeal membrane oxygenation (ECMO) refers to a life support machine. It is utilised by patients with severe illnesses that render their heart and lungs unable to function properly. ECMO replaces the functions of the heart and lungs in order to provide oxygen to the patient’s body and help them pump enough blood. The machine is linked to the patient's body with the help of plastic cannulas that pumps blood from the patient's body to an artificial lung, which adds oxygen to it and removes the carbon dioxide, after which the blood is sent back to the patient's body via another pump with the same pressure as the heart. Patients of all ages utilise ECMO during instances of heart and respiratory failure and in the process of cardiopulmonary resuscitation.

 

Global Extracorporeal Membrane Oxygenation Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By component, the market is divided into:

  • Pumps
  • Oxygenator
  • Controllers
  • Cannula
  • Accessories

On the basis of modality, the market can be segmented into:

  • Veno-Arterial
  • Veno-Venous 
  • Arterio- Venous

Based on patient type, the industry can be categorised into:

  • Neonates 
  • Paediatric
  • Adult

On the basis of application, the market can be distributed into:

  • Respiratory
  • Cardiac
  • Extracorporeal Cardiopulmonary Resuscitation (ECPR)

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Extracorporeal Membrane Oxygenation Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Heightened Prevalence of Cardiovascular Illnesses and the Rampant Spread of the Covid-19 Infection to Drive the Global Extracorporeal Membrane Oxygenation Industry

According to the WHO, cardiovascular diseases are a leading cause of death globally, with around 17.9 million casualties every year. In addition, most cardiovascular diseases are accompanied by pulmonary ailments such as chronic obstructive pulmonary disease (COPD) and emphysema, among others. In this regard, ECMO machines are widely utilised during the treatment and rehabilitation of patients. Moreover, due to the rampant spread of the Covid-19 virus worldwide, the demand for ECMO machines has increased significantly. These machines are essential in the treatment of patients with severe Covid-19 infection, as their weakened immunity and long-term symptoms make them susceptible to organ failure. These factors are estimated to positively impact the market growth in the forecast period.

 

Key Industry Players in the Global Extracorporeal Membrane Oxygenation Market

The report gives a detailed analysis of the following key players in the global extracorporeal membrane oxygenation market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Medtronic PLC
  • LivaNova PLC
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • Getinge AB 
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Component
  • Modality
  • Patient Type
  • Application
  • Region
Breakup by Component
  • Pumps
  • Oxygenator
  • Controllers
  • Cannula
  • Accessories
Breakup by Modality
  • Veno-Arterial
  • Veno-Venous
  • Arterio-Venous
Breakup by Patient Type
  • Neonates
  • Pediatric
  • Adult
Breakup by Application
  • Respiratory
  • Cardiac
  • Extracorporeal Cardiopulmonary Resuscitation (ECPR)
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Medtronic PLC
  • LivaNova PLC
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • Getinge AB
  • Maquet Holding
  • Medos Medizintechnik
  • Nipro Medical Corporation
  • CytoSorbents Corporation
  • EUROSETS S.R.L
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Extracorporeal Membrane Oxygenation Market Overview 

    3.1    Global Extracorporeal Membrane Oxygenation Market Historical Value (2017-2023) 
    3.2    Global Extracorporeal Membrane Oxygenation Market Forecast Value (2024-2032)
4    Global Extracorporeal Membrane Oxygenation Market Landscape
    4.1    Global Extracorporeal Membrane Oxygenation Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Extracorporeal Membrane Oxygenation Product Landscape
        4.2.1    Analysis by Component
        4.2.2    Analysis by Modality
        4.2.3    Analysis by Patient Type
        4.2.4    Analysis by Application
5    Global Extracorporeal Membrane Oxygenation Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Extracorporeal Membrane Oxygenation Market Segmentation 
    6.1    Global Extracorporeal Membrane Oxygenation Market by Component
        6.1.1    Market Overview                 
        6.1.2    Pumps
        6.1.3    Oxygenator
        6.1.4    Controllers
        6.1.5    Cannula
        6.1.6    Accessories
    6.2    Global Extracorporeal Membrane Oxygenation Market by Modality
        6.2.1    Market Overview
        6.2.2    Veno-Arterial
        6.2.3    Veno-Venous
        6.2.4    Arterio-Venous
    6.3    Global Extracorporeal Membrane Oxygenation Market by Patient Type
        6.3.1    Market Overview
        6.3.2    Neonates
        6.3.3    Pediatric
        6.3.4    Adult
    6.4    Global Extracorporeal Membrane Oxygenation Market by Application
        6.4.1    Market Overview
        6.4.2    Respiratory
        6.4.3    Cardiac
        6.4.4    Extracorporeal Cardiopulmonary Resuscitation (ECPR)
    6.5    Global Extracorporeal Membrane Oxygenation Market by Region
        6.5.1    Market Overview
        6.5.2    North America 
        6.5.3    Europe
        6.5.4    Asia Pacific
        6.5.5    Latin America
        6.5.6    Middle East and Africa
7    North America Extracorporeal Membrane Oxygenation Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Extracorporeal Membrane Oxygenation Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Extracorporeal Membrane Oxygenation Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Extracorporeal Membrane Oxygenation Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Extracorporeal Membrane Oxygenation Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Medtronic PLC
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    LivaNova PLC
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Terumo Corporation
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    MicroPort Scientific Corporation
        17.4.1    Financial Analysis
        17.4.2    Financial Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Getinge AB
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Maquet Holding
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Medos Medizintechnik
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Nipro Medical Corporation
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    CytoSorbents Corporation
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    EUROSETS S.R.L
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
18    Global Extracorporeal Membrane Oxygenation Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

In 2023, the market attained a value of approximately USD 241.67 million.

Over the forecast period of 2024-2032, the market is anticipated to grow at a CAGR of 4.8% to reach USD 368.53 million by 2032.

The major drivers of the industry such as the increased demand for ECMO machine for people suffering from cardiopulmonary diseases, rising geriatric population, steadily increasing patient population globally, and the rapid investments in the research and development of ECMO technology by the leading manufacturers are  driving the market growth.

The key market trends guiding the growth of the industry include the increased incidences of COVID-19 infections and heightened prevalence of cardiovascular diseases.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The market is divided based on component into pumps, oxygenator, controllers, cannula, and accessories.

The major segments based on modality include veno-arterial, veno-venous, and arterio-venous.

The significant segments based on patient type include neonates, paediatrics, and adults.

The major application segments include respiratory, cardiac, and extracorporeal cardiopulmonary resuscitation (ECPR).

The major players in the industry are Medtronic PLC, LivaNova PLC, Terumo Corporation, MicroPort Scientific Corporation, and Getinge AB, among others.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER